NFKB1 and lung adenocarcinoma: As shown through a series of in vitro and in vivo experiments, miR-1307-5p promotes the proliferation of lung adenocarcinoma, and miR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway.